Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
Archive
Volume 79, Issue 5
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Letter
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
Free
Online download statistics by month:
Online download statistics by month: April 2020 to May 2021
Abstract
Full
Pdf
Apr 2020
4825
4572
2203
May 2020
2315
1959
873
Jun 2020
716
595
293
Jul 2020
476
363
174
Aug 2020
304
251
81
Sep 2020
297
226
111
Oct 2020
249
223
80
Nov 2020
171
149
82
Dec 2020
183
154
56
Jan 2021
229
204
75
Feb 2021
166
151
45
Mar 2021
339
139
63
Apr 2021
196
163
53
May 2021
191
166
51
Total
10657
9315
4240
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF